Search - tctmd.com

Displaying 281 - 300 of 7110

Sort: Relevancy | Date

Presentation TCT 2016

ABSORB II Clinical Outcomes at 3 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Bernard R. Chevalier

October 31, 2016

Presentation TCT 2016

No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results

Presenter: Tony Das, Koen Deloose, Michael R. Jaff

October 31, 2016

Presentation TCT 2016

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Presenter: Stephen G. Ellis, Corrado Tamburino, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

No Metallic Implants Anymore: The Case for Routine DCB!

Presenter: Tony Das, Koen Deloose, Subhash Banerjee

October 31, 2016

Presentation TCT 2016

The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE

Presenter: Tony Das, Koen Deloose, Ehrin J. Armstrong

October 31, 2016

Presentation TCT 2016

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal Scaffold Dismantling)

Presenter: Elazer R. Edelman, Juan F. Granada

October 31, 2016

Presentation TCT 2016

Assessment and Implications of Vasomotion: Implications for BRS

Presenter: Elazer R. Edelman, Juan F. Granada, Habib Samady

October 31, 2016

Presentation TCT 2016

Benchtop Testing of BRS Mechanical Properties (General and Absorb Specific): Expansion, Recoil, Side Branches, and More

Presenter: Elazer R. Edelman, Juan F. Granada, Richard J. Rapoza

October 31, 2016

Presentation TCT 2016

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing II: Biomechanical Perspectives

Presenter: Elazer R. Edelman, Juan F. Granada

October 31, 2016

Presentation TCT 2016

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing I: Pathologic Perspectives

Presenter: Elazer R. Edelman, Juan F. Granada, Renu Virmani

October 31, 2016

Presentation TCT 2016

Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-Coated Balloon in Patients with Complex Femoropopliteal Lesions

Presenter: Thomas F. Luscher, Patrick W. Serruys, D. Christopher Metzger

October 31, 2016

Presentation TCT 2016

TCT 96: Progression of Coronary Atherosclerosis Despite Lipid-Lowering Therapy in Diabetic Patients Compared to Non-Diabetic Ones. Study With 3D Intravascular Ultrasound and Virtual Histology

Presenter: Farouc Jaffer, Amir Lerman, Tomas Kovarnik

October 31, 2016

Presentation TCT 2016

TCT 72: Short and Medium-term Clinical Outcome of Amphilimus Polymer-Free Drug-Eluting Stent in Diabetic Patients: An All-Comers Multicenter Spanish Registry (Control-8 Registry)

Presenter: Giuseppe De Luca, Christoph A. Kaiser, Antonio Gomez Menchero

October 31, 2016

Presentation TCT 2016

TCT 60: Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis From the ABSORB Randomized Trials

Presenter: Antonio L. Bartorelli, Kenneth Chin, Ariel Furer

October 31, 2016

Presentation TCT 2016

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Michael J. Cowley, Franz-Josef Neumann, Shunsuke Kubo

October 31, 2016

Presentation TCT 2016

Self-Expanding Stentys Stent In Various Anatomic Subsets: Evidence Of Clinical Benefit?

Presenter: Chaim S. Lotan, Giora Weisz, Francesco Prati

October 31, 2016

Presentation TCT 2016

TCT 83: Transcatheter Aortic Valve Replacement With Different Valve Designs for Elliptic Aortic Annulus Shape

Presenter: Mayra Guerrero, Roger J. Laham, Yoshio Maeno

October 31, 2016

Presentation TCT 2016

TCT 71: The NIREUS Randomized Trial: One-Year Results of the BioNIR Ridaforolimus-Eluting Coronary Stent System (BioNIR) European Angiography Study

Presenter: Giuseppe De Luca, Christoph A. Kaiser, Pieter C. Smits

October 31, 2016

Presentation TCT 2016

TCT 59: Overlapping Bioresorbable Coronary Devices: Immediate Results and Six-Month Follow-up of the REPARA Registry

Presenter: Antonio L. Bartorelli, Kenneth Chin, Felipe Hernandez

October 31, 2016

Presentation TCT 2016

TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry

Presenter: Michael J. Cowley, Franz-Josef Neumann, Joel Sainsous

October 31, 2016

Advertisement

ABSORB II Clinical Outcomes at 3 Years

No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

No Metallic Implants Anymore: The Case for Routine DCB!

The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal Scaffold Dismantling)

Assessment and Implications of Vasomotion: Implications for BRS

Benchtop Testing of BRS Mechanical Properties (General and Absorb Specific): Expansion, Recoil, Side Branches, and More

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing II: Biomechanical Perspectives

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing I: Pathologic Perspectives

Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-Coated Balloon in Patients with Complex Femoropopliteal Lesions

TCT 96: Progression of Coronary Atherosclerosis Despite Lipid-Lowering Therapy in Diabetic Patients Compared to Non-Diabetic Ones. Study With 3D Intravascular Ultrasound and Virtual Histology

TCT 72: Short and Medium-term Clinical Outcome of Amphilimus Polymer-Free Drug-Eluting Stent in Diabetic Patients: An All-Comers Multicenter Spanish Registry (Control-8 Registry)

TCT 60: Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis From the ABSORB Randomized Trials

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Self-Expanding Stentys Stent In Various Anatomic Subsets: Evidence Of Clinical Benefit?

TCT 83: Transcatheter Aortic Valve Replacement With Different Valve Designs for Elliptic Aortic Annulus Shape

TCT 71: The NIREUS Randomized Trial: One-Year Results of the BioNIR Ridaforolimus-Eluting Coronary Stent System (BioNIR) European Angiography Study

TCT 59: Overlapping Bioresorbable Coronary Devices: Immediate Results and Six-Month Follow-up of the REPARA Registry

TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content